Acquiring Company
Concentra Group Holdings Parent
Acquired Company
Elevation Oncology
AddisonBostonBiotechnologyHealth CareMedicalBiotechnologyHealthcareHealth CareMedicalGeneticsTherapeuticsDescription
Concentra has announced plans to acquire Elevation Oncology as part of its strategy targeting struggling biotech firms. The acquisition will lead to Elevation Oncology's shutdown, consistent with Concentra's approach to dealing with underperforming entities. This move continues Concentra's trend of consolidating resources within the biotech sector. Tang Capital Partners, which controls Concentra, has a history of similar acquisitions.
Quick answer
Concentra Group Holdings Parent is acquiring Elevation Oncology, announced June 20, 2025. Concentra Group Holdings Parent is based in Addison, Texas, United States.
- How much did Concentra Group Holdings Parent pay for Elevation Oncology?
- The deal value was not disclosed.
- What does Concentra Group Holdings Parent do?
- Concentra Group Holdings Parent, Inc. is the nation’s largest provider of occupational health services, dedicated to delivering superior outcomes and exceptional experiences to patients and customers.
- Where are Concentra Group Holdings Parent and Elevation Oncology based?
- Concentra Group Holdings Parent is based in Addison, Texas, United States. Elevation Oncology is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Concentra Group Holdings Parent?
- Fundz holds 5 contacts at Concentra Group Holdings Parent. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- BioMarin completes acquisition of Inozyme Pharma (July 1, 2025)
- AbbVie to acquire Cerevel Therapeutics for $45 per share (May 28, 2025)
- Supernus acquires SAGE Therapeutics for USD 8.50/share (July 31, 2025)
- AbbVie to acquire Capstan Therapeutics (July 15, 2025)
- AbbVie to acquire Capstan Therapeutics for $2.1B, $2.1B (June 30, 2025)
- Viemed acquires Lehan Medical Equipment for $28M, $28M (July 2, 2025)
Who to call at Concentra Group Holdings Parent, and when
When Concentra Group Holdings Parent changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Concentra Group Holdings Parent raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Concentra Group Holdings Parent, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Concentra Group Holdings Parent. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Concentra Group Holdings Parent makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Elevation Oncology?
Elevation Oncology was acquired by Concentra Group Holdings Parent, based in Addison. The deal was reported on June 20, 2025. Concentra Group Holdings Parent, Inc. is the nation’s largest provider of occupational health services, dedicated to delivering superior outcomes and exceptional experiences to patients and customers. Concentra Group Holdings Parent is publicly traded (CON) and operates in Biotechnology.
When did Concentra Group Holdings Parent acquire Elevation Oncology?
Concentra Group Holdings Parent's acquisition of Elevation Oncology was reported on June 20, 2025. Concentra has announced plans to acquire Elevation Oncology as part of its strategy targeting struggling biotech firms. The acquisition will lead to Elevation Oncology's shutdown, consistent with Concentra's approach to dealing with underperforming entities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Elevation Oncology do?
Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.